MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: MMS_Medical_Surgical Training & Simulation
Osso VR
Industry: Silicon Valley, California
Durect Corporation (NASDAQ: DRRX)
Organization & Developments: Durect
Parents
Durect Corporation (NASDAQ: DRRX)
Children
*DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development
2011: Durect Plunges on FDA Ruling (2011)
2017: Durect Takes A Beating On Pain Drug, Still holds Enormous Potential Value - Durect Corporation (NASDAQ:DRRX)
2018: DURECT Corporation: Upcoming Milestones And DUR-928 Progress - Durect Corporation (NASDAQ:DRRX)
2019: Durect Corporation: DUR-928 Data In Severe Alcoholic Hepatitis To Be Showcased At Upcoming AASLD Meeting_seekingalpha.com
2020: Durect Corporation (DRRX)_3 “Strong Buy” Healthcare Stocks With Triple-Digit Upside
2020: DURECT Corporation: DUR-928 May Benefit COVID-19 Patients With Acute Organ Injury
2020: Durect shares stumble as top drug fails mid-stage trial – Endpoints News
2020: Rockwell Medical (RMTI)_3 “Strong Buy” Healthcare Stocks With Triple-Digit Upside
2021: Durect: Positive Data In Alcoholic Hepatitis, But Catalysts Too Far Away
2023: DURECT: Reading Into AHFIRM Mortality Rates
Jumps
*Key People: Durect
Finance & Acquisitions: Durect